CD4 and neoplasm: In addition, flow cytometry (FCM) analysis of CD39 (encoded by ENTPD1) in HGSC samples revealed a greater expression in tumor-infiltrating Tregs compared to CD4+ and CD8+ effector T cells (Supplementary Fig. 5E), indicating that Tregs may account in a large part for ENTPD1 expression.